CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is an open-label, single-arm study to treat the adult R/R Large B-cell Lymphoma subjects with Relmacabtagene autoleucel (relma-cel) in China.
Epistemonikos ID: 53294a05c0685f1957bd53304fc63d5500dd1463
First added on: May 15, 2024